The correlation between in vitro and in vivo results reinforces the significance of c-Abl activity in mediating mitochondrial responses to stress conditions and the use of c-Abl inhibitors for targeting mitochondrial dysfunction in ALS. The gene discussed is ABL1; the disease is amyotrophic lateral sclerosis.